Accelerated chemically induced tumor development mediated by CD4+CD25+ regulatory T cells in wild-type hosts-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Accelerated chemically induced tumor development mediated by CD4+CD25+ regulatory T cells in wild-type hosts

Published:2005-06-16 Issue:26 Volume:102 Page:9253-9257
ISSN:0027-8424
Container-title:Proceedings of the National Academy of Sciences
language:en
Short-container-title:Proceedings of the National Academy of Sciences

Author:

Nishikawa H.,Kato T.,Tawara I.,Takemitsu T.,Saito K.,Wang L.,Ikarashi Y.,Wakasugi H.,Nakayama T.,Taniguchi M.,Kuribayashi K.,Old L. J.,Shiku H.

Publisher

Proceedings of the National Academy of Sciences

Subject

Multidisciplinary

Reference33 articles.

1. CD4+ CD25+ T cells responding to serologically defined autoantigens suppress antitumor immune responses

2. Human neoplasms elicit multiple specific immune responses in the autologous host.

3. Role of SEREX-defined immunogenic wild-type cellular molecules in the development of tumor-specific immunity

4. Definition of target antigens for naturally occurring CD4+ CD25+ regulatory T cells

5. Requirement for V α 14 NKT Cells in IL-12-Mediated Rejection of Tumors

Cited by 99 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Regulatory T cell-mediated immunosuppression orchestrated by cancer: towards an immuno-genomic paradigm for precision medicine;Nature Reviews Clinical Oncology;2024-02-29

2. Implications of regulatory T cells in anti-cancer immunity: from pathogenesis to therapeutics;Heliyon;2022-08

3. Taxol: Mechanisms of action against cancer, an update with current research;Paclitaxel;2022

4. Role of CD4+CD25+FOXP3+ TReg cells on tumor immunity;Immunological Medicine;2021-09-08

5. Inhibitory effects of a selective prostaglandin E2 receptor antagonist RQ-15986 on inflammation-related colon tumorigenesis in APC-mutant rats;PLOS ONE;2021-05-18

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3